COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Policy Brief

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Published date

October 22, 2020

Duke-Margolis Affiliated Authors

Image of Nicholas Harrison

Nicholas R. Harrison, MPH, MA

Senior Policy Analyst

Kroetsch

Adam Kroetsch, MPP

Research Director, Biomedical Innovation and Regulatory Policy
Senior Team Member

William K. Bleser - Margolis headhot

William K. Bleser, PhD, MSPH

Managing Associate, Payment Reform and Population Health
Senior Team Member
2020 Intern Mentor
Anti-Racism and Equity Committee Member

morgan romine

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty